LETROZ (LETROZOLE 2.5MG) FEMARA GENERIC – 5 TABS

SunPharma’s Letroz/Letrozole is approved for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Letrozole is a prescription medication in Kenya used to treat breast cancer in women who have already gone through menopause. Letroz 2.5mg belongs to a group of drugs called aromatase inhibitors. These work by decreasing the amount of estrogen produced by the body, which can slow and/or stop the growth of the cancer.